173 related articles for article (PubMed ID: 8589615)
1. Familial cutaneous melanoma.
Lucchina LC; Barnhill RL; Duke DM; Sober AJ
Melanoma Res; 1995 Dec; 5(6):413-8. PubMed ID: 8589615
[TBL] [Abstract][Full Text] [Related]
2. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
Szekeres L; Korom I
Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
[TBL] [Abstract][Full Text] [Related]
3. [Increased incidence of multiple melanoma in sporadic and familial dysplastic nevus cell syndrome].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Sep; 40(9):548-52. PubMed ID: 2807914
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary melanomas: analysis of 49 cases.
Savoia P; Quaglino P; Verrone A; Bernengo MG
Melanoma Res; 1998 Aug; 8(4):361-6. PubMed ID: 9764812
[TBL] [Abstract][Full Text] [Related]
5. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome.
Tiersten AD; Grin CM; Kopf AW; Gottlieb GJ; Bart RS; Rigel DS; Friedman RJ; Levenstein MJ
J Dermatol Surg Oncol; 1991 Jan; 17(1):44-8. PubMed ID: 1991880
[TBL] [Abstract][Full Text] [Related]
6. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
7. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
[TBL] [Abstract][Full Text] [Related]
8. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
9. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study.
Marghoob AA; Kopf AW; Rigel DS; Bart RS; Friedman RJ; Yadav S; Abadir M; Sanfilippo L; Silverman MK; Vossaert KA
Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716
[TBL] [Abstract][Full Text] [Related]
10. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
11. Melanoma risk in individuals with clinically atypical nevi.
Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of familial and non-familial melanoma in Australia.
Ang CG; Kelly JW; Fritschi L; Dowling JP
Melanoma Res; 1998 Oct; 8(5):459-64. PubMed ID: 9835460
[TBL] [Abstract][Full Text] [Related]
13. Risk of ocular melanoma in relation to cutaneous and iris naevi.
Bataille V; Sasieni P; Cuzick J; Hungerford JL; Swerdlow A; Bishop JA
Int J Cancer; 1995 Mar; 60(5):622-6. PubMed ID: 7860135
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
16. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
Bataille V; Bishop JA; Sasieni P; Swerdlow AJ; Pinney E; Griffiths K; Cuzick J
Br J Cancer; 1996 Jun; 73(12):1605-11. PubMed ID: 8664138
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
Schneider JS; Moore DH; Sagebiel RW
Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
[TBL] [Abstract][Full Text] [Related]
18. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy.
Manganoni AM; Zanotti F; Farisoglio C; Feroldi P; Facchetti F; Calzavara-Pinton P
Dermatol Online J; 2010 Jan; 16(1):17. PubMed ID: 20137759
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
20. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi.
Greene MH; Clark WH; Tucker MA; Kraemer KH; Elder DE; Fraser MC
Ann Intern Med; 1985 Apr; 102(4):458-65. PubMed ID: 3977193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
